|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Safety,pharmacokinetics,and efficacy of AMG 706,an oral multikinase inhibitor,in patients with advanced solid tumors显示文摘 | ROSEN LS KURZROCK R MULAY M | 2007 | J Clin Oncol2007，25，： | 1 |
| 2 | Safety, pharmacokinetics, and efficacy of AMG 706, an oral multikinase inhibitor, in patients with advanced solid tumors显示文摘 | Rosen LS Kurzrock R Mulay M | 2007 | J Clin Oncol2007，25，17： | 1 |
| 3 | Axitinib is an active treatment for all histologic subtypes of advanced thyroid 显示文摘 | Cohen EE Rosen LS Vokes EE | 2008 | Journal of Clinical Oncology2008，26，29： | 1 |
| 4 | Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma:a phase Ⅲ,double-blind,comparative trial显示文摘 | ROSEN LS GORDON D ANTONIO BS | 2001 | Cancer J2001，7，5： | 1 |
| 5 | Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors:A randomized,Phase Ⅲ double-blind,placebo-controlled trial显示文摘 | Rosen LS David G Simon T | 2004 | Cancer2004，100，12： | 1 |
| 6 | Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors:a phase Ⅲ, double-blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group显示文摘 | Rosen LS Gordon D Tchekmedyian S | 2003 | J Clin Oncol2003，21，6： | 1 |
| 7 | Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: A phase Ⅲ, double - blind, randomized trial The Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group 显示文摘 | Rosen LS Gordon D Tchekmedyian S | 2003 | J Clin Oncol2003，21，16： | 1 |
| 8 | Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma:a randomized,double-blind,multicenter,comparative trial显示文摘 | Rosen LS Gordon D Kaminski M | 2003 | Cancer2003，98，8： | 1 |
| 9 | Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial显示文摘 | Rosen LS Gordon D Kaminski M | 2003 | Cancer2003，98，： | 1 |
| 10 | Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma:A phase Ⅲ double-blind,comparative trial显示文摘 | Rosen LS Gordon D Antonio BS | 2001 | Cancer J2001，7，5： | 1 |
| 11 | A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors 显示文摘 | Jonker D J Rosen LS Sawyer MB | 2011 | Ann Oncol2011，22，6： | 1 |
| 12 | Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with none-small cell lung carcinoma and other solid tumors:a randomized,phase Ⅲ,double-blind,placebo-controlled trail显示文摘 | Rosen LS Gordon D Tchekmedyian NS | 2004 | Cancer2004，100，： | 1 |
| 13 | Efficacy and safety of zoledronic acid in the treatment of bone metastases associated with lung cancer and other solid tumors显示文摘 | Rosen LS | 2002 | Semin Oncol2002，29，621： | 1 |
| 14 | Safety and phar- macokinetics of ganitumab (AMG 479) combined with sorafenib, panitumumab, erlotinib, or gemeitabine in pa- tients with advanced solid tumors显示文摘 | Rosen LS Puzanov I Friberg G | 2012 | Clin Cancer Res2012，18，12： | 1 |
| 15 | Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase Ⅲ , double-blind, ran domized trial-the zoledronic acid Lung cancer and other solid tumors study group显示文摘 | Rosen LS Gordon D Tchekmedyian S | 2003 | J Clin Oncol2003，15，16： | 1 |
| 16 | Long- term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with non - small cell lung carcinoma and other solid tumors a randomized, phase Ⅲ double - blind, placebo - con -trolled trial显示文摘 | Rosen LS Gordon D Tchekmedyian NS | 2004 | Cancer2004，100，12： | 1 |
| 17 | Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer:results from a phase Ⅱ study显示文摘 | Cohen EE Rosen LS Vokes EE | 2008 | J Clin Oncol2008，26，29： | 1 |
| 18 | Sympathetic innervation modulates ventricular impulse propagation and repolarisation in the immature rat heart显示文摘 | Sun LS Legato M J Rosen TS | 1993 | Cardiovasc Res1993，27，3： | 1 |
| 19 | Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: A phase Ⅲ, double-blind, comparative trial 显示文摘 | Rosen LS Gordon D Kaminski M | 2001 | Cancer J2001，7，7： | 1 |
| 20 | Zoledronic acid issuperior to pamidronate for the treatment of bone metastases inbreast carcinoma patients with at least one osteolytic lesion 显示文摘 | Rosen LS Gordon DH Dugan W Jr | 2004 | Cancer2004，100，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员